Evidence map›Paper›PMID 33607996›Full record

ArticleBMC public health2021

Evaluating the independent influence of sexual transmission on HBV infection in China: a modeling study.

Miaolei Li, Jian Zu, Mingwang Shen, Guihua Zhuang, Siyuan Chen, Fuzhen Wang, Hui Zheng, Guomin Zhang

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Simple and Feasible Detection of Hepatitis B VirusFrontiers in molecular biosciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Miaolei LiSchool of Mathematics and Statistics, Xi'an Jiaotong University, Xi'an, Shaanxi, 710049, P. R. China.
Jian ZuSchool of Mathematics and Statistics, Xi'an Jiaotong University, Xi'an, Shaanxi, 710049, P. R. China. jianzu@xjtu.edu.cn.
Mingwang ShenSchool of Public Health, Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, P. R. China.
Guihua ZhuangSchool of Public Health, Health Science Center, Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, P. R. China.
Siyuan ChenDepartment of Statistics and Actuarial Science, Simon Fraser University, V5A1S6, Burnaby, British Columbia, Canada.
Fuzhen WangChinese Center for Disease Control and Prevention, Beijing, 102206, P. R. China.
Hui ZhengChinese Center for Disease Control and Prevention, Beijing, 102206, P. R. China.
Guomin ZhangChinese Center for Disease Control and Prevention, Beijing, 102206, P. R. China. zhanggm@chinacdc.cn.
Xi'an Jiaotong University · CNChinese Center For Disease Control and Prevention · CNSimon Fraser University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe long-term impact of sexual transmission on the hepatitis B virus (HBV) infection in China remains unclear. This study aims to estimate the independent influence of sexual transmission on HBV infection.

methodsBased on the natural history of HBV infection and three national serosurvey data of hepatitis B in China, we developed an age- and sex-specific discrete model to describe the transmission dynamics of HBV. The initial conditions of the model were determined according to the age- and sex-specific national serosurvey data in 1992. Based on the national survey data of hepatitis B in 1992 and 2006, by using the Markov Chain Monte Carlo (MCMC) method, we estimated the age- and sex-specific seroclearance rates of hepatitis B surface antigen (HBsAg) and the horizontal transmission rates as well as their 95% confidence intervals (CI). Then we used the age- and sex-specific national serosurvey data of hepatitis B in 2014 to test the accuracy of our model-based estimation. Finally, we evaluated the independent impact of sexual transmission on HBV infection and discussed the long-term effect of promotion of condom use in China.

resultsWe estimated that the annual rates of HBsAg seroclearance for males and females aged 1-59 years were respectively 1.04% (95% CI, 0.49-1.59%) and 1.92% (95% CI, 1.11-2.73%). Due to sexual transmission, in 2014, the total number of chronic HBV infections in people aged 0-100 years increased 292,581, of which males increased 189,200 and females increased 103,381. In 2006, the acute HBV infections due to sexual transmission accounted for 24.76% (male: 31.33%, female: 17.94%) and in 2014, which accounted for 34.59% (male: 42.93%, female: 25.73%). However, if the condom usage rate was increased by 10% annually starting in 2019, then compared with current practice, the total number of acute HBV infections from 2019 to 2035 would be reduced by 16.68% (male: 21.49%, female: 11.93%). The HBsAg prevalence in people aged 1-59 years in 2035 would be reduced to 2.01% (male: 2.40%, female: 1.58%).

conclusionsSexual transmission has become the predominant route of acute HBV infection in China, especially for men. The promotion of condom use plays a significant role in reducing the cases of acute HBV infection.

Indexed as

Hepatitis BHepatitis B virusAdolescentAdultAgedAged, 80 and overChildChild, PreschoolChinaFemaleHepatitis B e AntigensHepatitis B Surface AntigensHumansInfantInfant, NewbornMaleHepatitis B e AntigensHepatitis B Surface AntigensAge-structured modelCondom promotionHBsAg prevalenceHepatitis BSexual transmission

Identifiers

PMID33607996
PMCPMC7893752
OpenAlexW3133356504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.